Go Pro

Van Hulzen Asset Management LLC Takes Position in Xylem Inc. $XYL

Xylem logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Van Hulzen Asset Management initiated a position in Xylem during the second quarter, purchasing 11,800 shares valued at approximately $1.4 million. Institutional investors and hedge funds collectively own 87.96% of the company.
  • Xylem reported quarterly earnings of $1.46 per share, beating estimates of $1.34, while revenue reached $2.34 billion and rose 1.5% year over year. The company maintained fiscal 2026 EPS guidance of $5.55 to $5.70.
  • Analysts maintain a “Moderate Buy” consensus with an average price target of $155, compared with the stock’s recent price of $114.18. Xylem also declared a quarterly dividend of $0.43 per share, representing a 1.5% yield.
  • MarketBeat previews the top five stocks to own by September 1st.

Van Hulzen Asset Management LLC bought a new stake in Xylem Inc. (NYSE:XYL - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 11,800 shares of the industrial products company's stock, valued at approximately $1,395,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Commonwealth Retirement Investments LLC bought a new stake in shares of Xylem during the fourth quarter valued at approximately $27,000. Wexford Capital LP acquired a new position in shares of Xylem during the third quarter worth approximately $27,000. Dunhill Financial LLC bought a new position in shares of Xylem in the 2nd quarter worth $30,000. Avalon Trust Co bought a new position in shares of Xylem in the 2nd quarter worth $35,000. Finally, Global Assets Advisory LLC acquired a new stake in Xylem in the 1st quarter valued at $40,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Trading Up 0.7%

NYSE XYL opened at $114.18 on Tuesday. The firm has a market capitalization of $26.66 billion, a P/E ratio of 27.19, a PEG ratio of 1.57 and a beta of 1.02. The business has a fifty day simple moving average of $118.10 and a 200 day simple moving average of $119.50. Xylem Inc. has a 12 month low of $105.29 and a 12 month high of $154.27. The company has a current ratio of 1.61, a quick ratio of 1.24 and a debt-to-equity ratio of 0.23.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.12. The business had revenue of $2.34 billion for the quarter, compared to analysts' expectations of $2.34 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The business's revenue was up 1.5% on a year-over-year basis. During the same period last year, the business earned $1.26 EPS. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. On average, analysts predict that Xylem Inc. will post 5.67 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 24th. Investors of record on Thursday, August 27th will be issued a dividend of $0.43 per share. The ex-dividend date is Thursday, August 27th. This represents a $1.72 annualized dividend and a yield of 1.5%. Xylem's payout ratio is 40.95%.

Analysts Set New Price Targets

A number of analysts have commented on XYL shares. Jefferies Financial Group boosted their price target on shares of Xylem from $145.00 to $150.00 and gave the company a "buy" rating in a research note on Monday. Citigroup reaffirmed a "buy" rating on shares of Xylem in a research note on Wednesday, July 29th. Oppenheimer reduced their price objective on shares of Xylem from $160.00 to $158.00 and set an "outperform" rating for the company in a report on Wednesday, April 29th. Barclays boosted their target price on shares of Xylem from $154.00 to $159.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 29th. Finally, Royal Bank Of Canada raised their price target on shares of Xylem from $159.00 to $164.00 and gave the company an "outperform" rating in a research report on Wednesday, July 29th. Nine investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Xylem currently has an average rating of "Moderate Buy" and a consensus target price of $155.00.

View Our Latest Report on Xylem

About Xylem

(Free Report)

Xylem Inc NYSE: XYL is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Recommended Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines